FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 176 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 10.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $129,000 | +396.2% | 3,426 | +122.8% | 0.00% | +100.0% |
| Q4 2020 | $26,000 | -84.0% | 1,538 | -95.5% | 0.00% | -50.0% |
| Q3 2020 | $162,000 | +237.5% | 34,445 | +339.6% | 0.00% | 0.0% |
| Q2 2020 | $48,000 | +92.0% | 7,835 | +19.5% | 0.00% | 0.0% |
| Q3 2019 | $25,000 | -24.2% | 6,557 | +22.0% | 0.00% | 0.0% |
| Q2 2019 | $33,000 | +725.0% | 5,374 | +1691.3% | 0.00% | – |
| Q1 2019 | $4,000 | 0.0% | 300 | +1.4% | 0.00% | – |
| Q3 2018 | $4,000 | +300.0% | 296 | +335.3% | 0.00% | – |
| Q2 2018 | $1,000 | -96.8% | 68 | -96.2% | 0.00% | -100.0% |
| Q1 2018 | $31,000 | -18.4% | 1,812 | +3.9% | 0.00% | -40.0% |
| Q4 2017 | $38,000 | +322.2% | 1,744 | +726.5% | 0.01% | +400.0% |
| Q3 2017 | $9,000 | +200.0% | 211 | +111.0% | 0.00% | – |
| Q2 2017 | $3,000 | -94.6% | 100 | -91.1% | 0.00% | -100.0% |
| Q4 2016 | $56,000 | +1766.7% | 1,123 | +2146.0% | 0.01% | – |
| Q3 2016 | $3,000 | -40.0% | 50 | -56.1% | 0.00% | -100.0% |
| Q1 2016 | $5,000 | -76.2% | 114 | -91.6% | 0.00% | -50.0% |
| Q3 2015 | $21,000 | +75.0% | 1,364 | +171.7% | 0.00% | +100.0% |
| Q2 2015 | $12,000 | -86.2% | 502 | -86.7% | 0.00% | -90.9% |
| Q1 2015 | $87,000 | +295.5% | 3,780 | +358.7% | 0.01% | +450.0% |
| Q4 2014 | $22,000 | +450.0% | 824 | +116.3% | 0.00% | – |
| Q3 2014 | $4,000 | -92.3% | 381 | -88.7% | 0.00% | -100.0% |
| Q2 2014 | $52,000 | +5100.0% | 3,368 | +5513.3% | 0.01% | – |
| Q1 2014 | $1,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|